L. Roy Papp & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.09M | Sell |
8,457
-369
| -4% | -$43.2K | 0.11% | 92 |
|
|
2026
Q1 | $1.06M | Buy |
8,826
+52
| +0.6% | +$6K | 0.12% | 95 |
|
|
2025
Q4 | $924K | Buy |
8,774
+428
| +5% | +$40.2K | 0.1% | 100 |
|
|
2025
Q3 | $700K | Sell |
8,346
-583
| -7% | -$48K | 0.08% | 109 |
|
|
2025
Q2 | $707K | Buy |
8,929
+1
| +0% | +$79 | 0.08% | 103 |
|
|
2025
Q1 | $801K | Sell |
8,928
-89
| -1% | -$8.31K | 0.1% | 100 |
|
|
2024
Q4 | $897K | Buy |
9,017
+1
| +0% | +$103 | 0.1% | 100 |
|
|
2024
Q3 | $1.02M | Hold |
9,016
| – | – | 0.12% | 94 |
|
|
2024
Q2 | $1.12M | Buy |
9,016
+1
| +0% | +$129 | 0.14% | 88 |
|
|
2024
Q1 | $1.19M | Sell |
9,015
-333
| -4% | -$41K | 0.14% | 90 |
|
|
2023
Q4 | $1.02M | Sell |
9,348
-149
| -2% | -$15.5K | 0.13% | 94 |
|
|
2023
Q3 | $978K | Buy |
9,497
+21
| +0.2% | +$2.26K | 0.13% | 95 |
|
|
2023
Q2 | $1.09M | Buy |
9,476
+237
| +3% | +$26.9K | 0.14% | 90 |
|
|
2023
Q1 | $983K | Sell |
9,239
-229
| -2% | -$24.7K | 0.13% | 94 |
|
|
2022
Q4 | $1.05M | Sell |
9,468
-403
| -4% | -$41.2K | 0.15% | 91 |
|
|
2022
Q3 | $850K | Buy |
9,871
+101
| +1% | +$9.02K | 0.13% | 98 |
|
|
2022
Q2 | $891K | Buy |
9,770
+138
| +1% | +$12.2K | 0.13% | 103 |
|
|
2022
Q1 | $790K | Sell |
9,632
-29
| -0.3% | -$2.29K | 0.1% | 110 |
|
|
2021
Q4 | $740K | Buy |
9,661
+1
| +0% | +$80 | 0.08% | 116 |
|
|
2021
Q3 | $726K | Sell |
9,660
-399
| -4% | -$30.3K | 0.09% | 113 |
|
|
2021
Q2 | $782K | Buy |
10,059
+425
| +4% | +$31.6K | 0.1% | 109 |
|
|
2021
Q1 | $709K | Sell |
9,634
-3,239
| -25% | -$239K | 0.1% | 108 |
|
|
2020
Q4 | $1M | Buy |
12,873
+1
| +0% | +$76 | 0.12% | 98 |
|
|
2020
Q3 | $1.02M | Buy |
12,872
+2,024
| +19% | +$159K | 0.13% | 93 |
|
|
2020
Q2 | $800K | Buy |
10,848
+132
| +1% | +$9.94K | 0.11% | 99 |
|
|
2020
Q1 | $787K | Buy |
10,716
+735
| +7% | +$57.8K | 0.14% | 98 |
|
|
2019
Q4 | $866K | Buy |
9,981
+114
| +1% | +$9.36K | 0.12% | 104 |
|
|
2019
Q3 | $793K | Sell |
9,867
-367
| -4% | -$29.4K | 0.12% | 107 |
|
|
2019
Q2 | $819K | Buy |
10,234
+1
| +0% | +$77 | 0.13% | 103 |
|
|
2019
Q1 | $812K | Sell |
10,233
-2,985
| -23% | -$223K | 0.15% | 91 |
|
|
2018
Q4 | $964K | Sell |
13,218
-424
| -3% | -$29.9K | 0.2% | 83 |
|
|
2018
Q3 | $923K | Sell |
13,642
-138
| -1% | -$8.79K | 0.16% | 89 |
|
|
2018
Q2 | $798K | Sell |
13,780
-3,219
| -19% | -$182K | 0.15% | 95 |
|
|
2018
Q1 | $884K | Buy |
16,999
+4,902
| +41% | +$265K | 0.17% | 92 |
|
|
2017
Q4 | $650K | Buy |
12,097
+458
| +4% | +$25.4K | 0.13% | 101 |
|
|
2017
Q3 | $711K | Buy |
11,639
+41
| +0.4% | +$2.49K | 0.15% | 88 |
|
|
2017
Q2 | $709K | Sell |
11,598
-2,305
| -17% | -$140K | 0.15% | 92 |
|
|
2017
Q1 | $843K | Sell |
13,903
-208
| -1% | -$12.6K | 0.19% | 81 |
|
|
2016
Q4 | $793K | Hold |
14,111
| – | – | 0.18% | 90 |
|
|
2016
Q3 | $840K | Buy |
14,111
+1
| +0% | +$58 | 0.19% | 84 |
|
|
2016
Q2 | $776K | Hold |
14,110
| – | – | 0.18% | 94 |
|
|
2016
Q1 | $712K | Buy |
14,110
+513
| +4% | +$25.1K | 0.17% | 95 |
|
|
2015
Q4 | $685K | Buy |
13,597
+116
| +0.9% | +$5.85K | 0.17% | 91 |
|
|
2015
Q3 | $635K | Buy |
13,481
+1,692
| +14% | +$89.9K | 0.16% | 94 |
|
|
2015
Q2 | $640K | Buy |
11,789
+16
| +0.1% | +$897 | 0.15% | 94 |
|
|
2015
Q1 | $646K | Buy |
11,773
+100
| +0.9% | +$5.66K | 0.14% | 99 |
|
|
2014
Q4 | $633K | Hold |
11,673
| – | – | 0.14% | 97 |
|
|
2014
Q3 | $660K | Hold |
11,673
| – | – | 0.15% | 93 |
|
|
2014
Q2 | $644K | Hold |
11,673
| – | – | 0.14% | 95 |
|
|
2014
Q1 | $632K | Sell |
11,673
-262
| -2% | -$13.6K | 0.15% | 92 |
|
|
2013
Q4 | $570K | Sell |
11,935
-262
| -2% | -$12K | 0.12% | 95 |
|
|
2013
Q3 | $554K | Buy |
12,197
+1,992
| +20% | +$90.9K | 0.13% | 91 |
|
|
2013
Q2 | $452K | Buy |
+10,205
| New | +$456K | 0.11% | 98 |
|
Other funds holding MRK
ECSS
L. Roy Papp & Associates's MRK Position: Q2 2026 in Review
L. Roy Papp & Associates reduced its Merck (MRK) stake by 4.2% in Q2 2026, selling an estimated $43.2K and leaving 8,457 shares worth $1.09M. The position accounts for 0.11% of the portfolio, ranked #92.
L. Roy Papp & Associates first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.19M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- L. Roy Papp & Associates held 8,457 shares of Merck worth $1.09M as of Q2 2026.
- L. Roy Papp & Associates sold 369 Merck shares in Q2 2026, an estimated $43.2K.
- Merck made up 0.11% of L. Roy Papp & Associates's portfolio in Q2 2026, its #92 holding.
- L. Roy Papp & Associates first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
- L. Roy Papp & Associates's Merck position peaked at $1.19M in Q1 2024.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on L. Roy Papp & Associates's 13F filing for Q2 2026, filed 23 Jul 2026.